PART-I: A novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12

Cancer Research

Volumn 60, Issue 4, 2000, Pages 858-863

  Lin, Biaoyang ^a   White, James T ^a   Ferguson, Camari ^a   Bumgarner, Roger ^a   Friedman, Cynthia ^a   Trask, Barbara ^a   Ellis, William ^b   Lange, Paul ^b   Hood, Leroy ^a   Nelson, Peter S ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN; MESSENGER RNA;

ARTICLE; BINDING SITE; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME 5Q; CHROMOSOME MAP; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CARCINOMA; TUMOR SUPPRESSOR GENE; AMINO ACID SEQUENCE; CHROMOSOME 5; DRUG EFFECT; GENE EXPRESSION REGULATION; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEIC ACID HYBRIDIZATION; PROSTATE;

AMINO ACID SEQUENCE; ANDROGENS; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 5; GENE EXPRESSION REGULATION; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; PROMOTER REGIONS (GENETICS); PROSTATE; RNA, MESSENGER;

EID: 0034651241     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bonkhoff, H., and Remberger, K. Differentialion pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate, 28: 98-106, 1996.
2. Denmeade, S. R., Lin, X. S., and Isaacs, J. T. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate, 28: 251-265, 1996.
3. Isaacs, J. T., Wake, N., Coffey, D. S., and Sandberg, A. A. Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system. Cancer Res., 42: 2353-2371, 1982.
4. Bruchovsky, N., Brown, E. M., Coppin, C. M., Goldenberg, S. L., Le Riche, J. C., Murray, N. C., and Rennie, P. S. The endocrinology and treatment of prostate tumor progression. Prog. Clin. Biol. Res., 239: 347-387, 1987.
5. Rittenhouse, H. G., Finlay, J. A., Mikolajczyk, S. D., and Partir, A. W. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci., 35: 275-368, 1998.
6. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
7. Hawkins, V., Doll, D., Bumgarner, R., Smith, T., Abajian, C., Hood, L., and Nelson, P. S. PEDB: The Prostate Expression Database. Nucleic Acids Res., 27: 204-208, 1999.
8. Nelson, P. S., Ng, W. L., Schummer, M., True, L. D., Liu, A. Y., Bumgarner, R. E., Ferguson, C., Dimak, A., and Hood, L. An expressed-sequence-tag database of the human prostate: sequence analysis of 1168 cDNA clones. Genomics, 47: 12-25, 1998.
9. Trask, B. J. Fluorescence in Situ Hybridization. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1997.
10. Wise, C. A., Clines, G. A., Massa, H., Trask, B. J., and Lovett, M. Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family. Genome Res., 7: 10-16, 1997.
11. Riegman, P. H., Vlietstra, R. J., van der Korput, J. A., Brinkmann, A. O., and Trapman, S. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol. Endocrinol., 5: 1921-1930, 1991.
12. Murtha, P., Tindall, D. J., and Young, C. Y. Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry, 32: 6459-6464, 1993.
13. Paoloni-Giacobino, A., Chen, H., Peitsch, M. C., Rossier, C., and Antonarakis, S. E. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics, 44: 309-320, 1997.
14. Lin, B., Ferguson, C., White, J. T., Wang, S., Vessella, R., True, L. D., Hood, L., and Nelson, P. S. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res., 59: 4180-4184, 1999.
15. Troyer, J. K., Beckelt, M. L., and Wright, G. L., Jr. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int. J. Cancer, 62: 552-558, 1995.
16. Kozak, M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res., 15: 8125-8148, 1987.
17. Wilusz, J., Pettine, S. M., and Shenk, T. Functional analysis of point mutations in the AAUAAA motif of the SV40 late polyadenylation signal. Nucleic Acids Res., 17: 3899-3908, 1989.
18. Lin, B., Rommens, J. M., Graham, R K., Kalchman, M., MacDonald, H., Nasir, J., Delaney, A., Goldberg, Y. P., and Hayden. M. R. Differential 3′ polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression. Hum. Mol. Genet., 2: 1541-1545, 1993.
19. Henikoff, J. G., Henikoff, S., and Pietrokovski, S. New features of the Blocks Database servers. Nucleic Acids Res., 27: 226-228, 1999.
20. Mieczkowski, P. A., Fikus, M. U., and Ciesla, Z. Characterization of a novel DNA damage-inducible gene of Saccharomyces cerevisiae, DIN7, which is a structural homolog of the RAD2 and RAD27 DNA repair genes. Mol. Gen. Genet., 253: 655-665, 1997.
21. O'Donovan, A., Scherly, D., Clarkson, S. G., and Wood, R. D. Isolation of active recombinant XPG protein, a human DNA repair endonuclease. J. Biol. Chem., 269: 15965-15968, 1994.
22. Van Dijk, M. A., Voorhoeve, P. M., and Murre, C. Pbxl is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia. Proc. Natl. Acad. Sci. USA, 90: 6061-6065, 1993.
23. Rao, A. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes, Immunol. Today, 15: 274-281, 1994.
24. Schuurmans, A. L., Bolt, J., Voorhorst, M. M., Blankenstein, R. A., and Mulder, E. Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids. Int. J. Cancer, 42: 917-922, 1988.
25. Swinnen, J. V., and Verhoeven. G. Androgens and the control of lipid metabolism in human prostate cancer cells. J. Steroid Biochem. Mol. Biol., 65: 191-198, 1998.
26. Wang, Z., Tufts, R., Haleem, R., and Cai, X. Genes regulated by androgen in the rat ventral prostate. Proc. Natl. Acad. Sci. USA, 94: 12999-13004, 1997.
27. McEwan, I. J., and Gustafsson, J. Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. Proc. Natl. Acad. Sci. USA, 94: 8485-8490, 1997.
28. He, W. W., Sciavolino, P. J., Wing, J., Augustus, M., Hudson, P., Meissner, P. S., Curtis, R. T., Shell, B. K., Bostwick, D. G., Tindall, D. J., Gelmann, E. P., Abate-Shen, C., and Carter, K. C. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics, 43: 69-77, 1997.
29. Prescott, J. L., Blok, L., and Tindall, D. J. Isolation and androgen regulation of the human homeobox cDNA, NKX3.1. Prostate, 35: 71-80, 1998.
30. Patrikainen, L., Shan, J., Porvari, K., and Vihko, P. Identification of the deoxyribonucleic acid-binding site of a regulatory protein involved in prostate-specific and androgen receptor-dependent gene expression. Endocrinology. 140: 2063-2070, 1999.
31. Ozen, M., Navone, N. M., Multani, A. S., Troncoso, P., Logothetis, C. J., Chung, L. W., von Eschenbach, A. C., and Pathak, S. Structural alterations of chromosome 5 in twelve human prostate cancer cell lines. Cancer Genet. Cytogenet., 106: 105-109, 1998.
32. Cher, M. L., Bova, G. S., Moore, D. H., Small, E. J., Carroll, P. R., Pin, S. S., Epstein, J. I., Isaacs, W. B., and Jensen, R. H. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res., 56: 3091-3102, 1996.
33. Ewing, C. M., Ru, N., Morion, R. A., Robinson, J. C. Wheelock, M. J., Johnson, K. R., Barrett, J. C., and Isaacs, W. B. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of α-catenin and restoration of E-cadherin function. Cancer Res., 55: 4813-4817, 1995.